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Abstract
Background: Stroke prevention requires effective treatment of its causes. Many etiological factors for stroke have been
identified, but the potential gain of effective intervention on these factors in terms of numbers of actually prevented strokes
remains unclear because of the lack of data from cohort studies. We assessed the impact of currently known potentially
modifiable etiological factors on the occurrence of stroke.
Methods and Findings: This population-based cohort study was based on 6,844 participants of the Rotterdam Study who
were aged $55 y and free from stroke at baseline (1990–1993). We computed population attributable risks (PARs) for
individual risk factors and for risk factors in combination to estimate the proportion of strokes that could theoretically be
prevented by the elimination of etiological factors from the population. The mean age at baseline was 69.4 y (standard
deviation 6.3 y). During follow-up (mean follow-up 12.9 y, standard deviation 6.3 y), 1,020 strokes occurred. The age- and
sex-adjusted combined PAR of prehypertension/hypertension, smoking, diabetes mellitus, atrial fibrillation, coronary
disease, and overweight/obesity was 0.51 (95% CI 0.41–0.62) for any stroke; hypertension and smoking were the most
important etiological factors. C-reactive protein, fruit and vegetable consumption, and carotid intima-media thickness in
combination raised the total PAR by 0.06. The PAR was 0.55 (95% CI 0.41–0.68) for ischemic stroke and 0.70 (95% CI 0.45–
0.87) for hemorrhagic stroke. The main limitations of our study are that our study population comprises almost exclusively
Caucasians who live in a middle and high income area, and that risk factor awareness is higher in a study cohort than in the
general population.
Conclusions: About half of all strokes are attributable to established causal and modifiable factors. This finding encourages
not only intervention on established etiological factors, but also further study of less well established factors.
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Introduction
In the 1960s it was discovered that treatment of high blood
pressure reduces the occurrence of stroke among persons with
severe diastolic hypertension by more than 90% [1]. The
observation that a relatively simple intervention prevents such a
devastating disease continues to inspire researchers to search for
other potentially modifiable etiological factors for stroke up to the
present day.
This search has led to the identification of many other risk
factors for stroke, some of which merely mark the increased risk
without playing a role in the causal pathway (risk indicators), and
some of which are presumably causal (etiological factors, or causal
risk factors) [2,3]. The impact of a causal risk factor on the burden
of stroke is determined by the proportion of strokes in which the
risk factor plays an indispensable role in the pathophysiological
pathway, in other words, the proportion of strokes that would not
have occurred had that risk factor not been present. This
proportion is called the population attributable risk (PAR) [4]. A
PAR indicates the maximum proportion of strokes that may be
prevented by complete elimination of the risk factor, which is of
course only relevant for etiological factors that can be modified.
The PAR of an etiological factor depends on both the strength of
the association between the etiological factor and the disease and
on the prevalence of the risk factor.
Previously, PARs have been estimated for various individual
etiological factors [3]. The proportion of strokes that can
theoretically be prevented by optimal treatment of all known
etiological factors for stroke cannot be calculated by simply adding
up the adjusted PARs of the individual etiological factors: this will
lead to an overestimation of the total PAR, and the total sum of
the PARs may easily exceed 100%. To calculate a total PAR from
multiple etiological factors, special statistical techniques need to be
applied that allow a single case to be attributed to multiple
etiological factors: as a rule, multiple (known and unknown)
etiological factors need to be present for a stroke to occur, and
adequate adjustment for confounding and interaction does not
sufficiently correct for this [5]. To our knowledge, no previous
cohort studies of stroke have reported the total PAR of multiple
etiological factors combined. The reports that exist are either
case–control studies [2,6,7] or did not use optimal statistical
techniques [2]; all previous studies therefore likely overestimated
the total PAR for stroke [4].
We were interested in finding out which proportion of strokes
can theoretically be prevented by optimal treatment of all known
etiological factors, and thereby how closely we have approached
our ultimate goal of finding a modifiable cause for every occurring
stroke. Therefore, we assessed the impact of potentially modifiable
etiological factors on the occurrence of stroke in a large
population-based cohort study among persons aged 55 y and over.
Methods
Ethics Statement
This study was approved by the Medical Ethics Committee of
the Erasmus Medical Center. All participants gave written
informed consent to participate in the study. Clinical investigations
were conducted according to the principles expressed in the
Declaration of Helsinki.
Study Population
The Rotterdam Study is an ongoing prospective population-
based cohort study that focuses on the causes and consequences of
chronic and disabling diseases in the elderly [8]. The cohort
started enrollment in 1990 and included 7,983 participants aged$
55 y living in Ommoord, a district of the city of Rotterdam in the
Netherlands (participation rate 78%).
Assessment of Stroke
Stroke was defined according to World Health Organization
criteria as a syndrome of rapidly developing clinical signs of focal (or
global) disturbance of cerebral function, with symptoms lasting 24 h
or longer or leading to death, with no apparent origin other than
vascular [9]. History of stroke at baseline was assessed during the
baseline interview and verified by reviewing medical records. After
enrollment, participants were continuously monitored for incident
stroke through automated linkage of the study database with
medical records from general practitioners. Nursing home physi-
cians’ records and records from the general practitioners of
participants who moved out of the district were checked on a
regular basis as well. Additional information was obtained from
hospital records. Potential strokes identified in medical records were
reviewed by research physicians, and verified by an experienced
stroke neurologist (P. J. K.) [10]. A stroke was subclassified as
ischemic if a CT or MRI scan confirmed the diagnosis, or if indirect
evidence (deficit limited to one limb or completely resolved within
72 h, atrial fibrillation in absence of anticoagulants) pointed at the
stroke having an ischemic nature. A stroke was subclassified as
hemorrhagic if a relevant hemorrhage was present on the CT or
MRI scan. If we could not retrieve enough information to subclassify
a stroke as hemorrhagic or ischemic, it was called unspecified. These
classifications corresponded to ICD-10 codes I61, I63, and I64,
respectively. Transient ischemic attacks or subarachnoid hemor-
rhages were not included. Follow-up was complete until January 1,
2012, for 97.1% of potential person-years [11].
Selection and Measurement of Etiological Factors for
Stroke
We selected etiological risk factors for stroke from the Guidelines
for the Primary Prevention of Stroke from the American Heart
Association/American Stroke Association [3]. We explain in
Table 1 how we incorporated these etiological factors in our study.
Blood pressure was measured twice in sitting position on the
right arm with a random-zero sphygmomanometer. We used the
average of these two measurements in the analyses to classify
participants as having no hypertension (systolic #120 mmHg and
diastolic#80 mm Hg), prehypertension (systolic.120 mm Hg or
diastolic .80 mm Hg), stage I hypertension (systolic .
140 mm Hg or diastolic .90 mm Hg), or stage II hypertension
(systolic .160 mm Hg or diastolic .100 mm Hg). Use of
antihypertensive medication was assessed during a home inter-
view. Treated hypertension was considered controlled if, with
treatment, the blood pressure measurement did not the fulfill
criteria for stage I or II hypertension. Body mass index (BMI)
measured at baseline was categorized as normal (BMI,25 kg/
m2), overweight (25–30 kg/m2), or obese (.30 kg/m2). Smoking
habits were assessed during the home interview and classified as
never, former, or current. The number of pack-years of smoking
was calculated by multiplying the number of cigarette packs
smoked per day by the number of years smoked. The threshold
between light and heavy smoking was defined as the median
number of pack-years, calculated for former smokers and current
smokers separately. We defined diabetes mellitus as a random or
post-load glucose level of 11.1 mmol/l or higher, or use of
antidiabetic medication. Atrial fibrillation was considered present
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when seen on an electrocardiogram during the baseline research
center visit or when it was reported in medical records. History of
angina pectoris was assessed with the Rose questionnaire [12].
History of percutaneous transluminal coronary angioplasty
(PTCA) or coronary artery bypass graft (CABG) and history of
myocardial infarction were positive if reported by the participant
and confirmed by electrocardiogram or medical records. Coro-
nary disease was defined as history of angina pectoris, myocardial
infarction, PTCA, or CABG. Total cholesterol (TC), high-density
lipoprotein (HDL), and C-reactive protein were measured in non-
fasting baseline serum with automated enzymatic procedures [13].
Carotid intima-media thickness (IMT) was measured by longitu-
dinal 2-dimensional ultrasound of the carotid artery [14]. Alcohol
intake and fruit and vegetable consumption were assessed by
means of a food frequency questionnaire in participants who were
not demented at baseline [15]. Excessive alcohol intake was
defined as more than 3 units (32 g) of alcohol per day. Fruit and
vegetable consumption was categorized as adequate (.5 fruit
and/or vegetable servings per day), low (3–5 servings per day), or
very low (,3 servings per day) (one serving of fruit was 80 g, and
one serving of vegetables was 77 g).
Population for Analysis
Of all 7,983 participants who were enrolled into the Rotterdam
Study, 7,717 were free from stroke at study baseline. After
exclusion of participants who refused informed consent for
retrieval of stroke follow-up data (n=171) and of those who had
incomplete data collection (no baseline research center visit)
(n=702), 6,844 participants could be included in the present
analyses.
C-reactive protein, alcohol intake, fruit and vegetable con-
sumption, and carotid IMT were assessed only in random
subgroups of the cohort [13,16]; alcohol intake and fruit and
vegetable consumption were not assessed in participants with
dementia at baseline [17]. Therefore, these factors were studied in
combination in a subgroup of 3,570 participants who had
complete assessment of all covariates.
Statistical Analysis
PARs and 95% CIs were calculated with the Interactive Risk
Attributable Program (US National Cancer Institute) [18]. This
program estimates the PAR adjusted for confounding by
PAR~1{
XI
i~1
XJ
j~1
rijR
{1
iDj ð1Þ
where
RiDj~
Pr D~1DX~xi,C~cj
 
Pr D~1DX~x1,C~cj
  ð2Þ
Table 1. Relationship between the etiological factors described in the 2011 American Heart Association/American Stroke
Association guidelines [3] and the etiological factors used in our study.
Etiological Factors Described in the 2011 American Heart Association/American Stroke
Association Guidelines Etiological Factors in Our Study
Well-documented and modifiable risk factors
Hypertension Blood pressure and blood-pressure-lowering medication
Cigarette smoking Current and former light and heavy smoking
Diabetes Diabetes mellitus
Dyslipidemia TC/HDL ratio
Atrial fibrillation Atrial fibrillation
Other cardiac conditions Angina pectoris, CABG, PTCA, myocardial infarction
Asymptomatic carotid stenosis Carotid IMT (subcohort)
Sickle cell disease .97% Caucasians in our study population
Postmenopausal hormone therapy Rare in our study population (#1,3% at baseline)
Oral contraceptives All participants aged $55 y at baseline in our study
Diet and nutrition Fruit and vegetable consumption (subcohort)
Physical inactivity No data available
Obesity and body fat distribution BMI
Less well-documented or potentially modifiable risk factors
Migraine No data available
Metabolic syndrome No data available on additional components
Alcohol consumption 0 units and $3 units of alcohol compared to 1–2 units per day
(subcohort)
Drug abuse Rare in our study population
Sleep-disordered breathing No data available
Hyperhomocysteinemia No data available
Elevated lipoprotein(a) Data available only in limited subcohort
Hypercoagulability No data available
Inflammation and infection C-reactive protein quartiles (subcohort)
The classification into well-documented and modifiable risk factors versus less well-documented or potentially modifiable risk factors is adopted from the guidelines.
doi:10.1371/journal.pmed.1001634.t001
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and
rij~Pr X~xi,C~cj D ~1
  ð3Þ
with D=1 denoting presence of disease, X denoting exposure with
i levels, and C denoting a confounder with j levels. The relative risk
is estimated from a multivariable Poisson model [19,20].
The PAR for a combination of risk factors corresponds to the
proportion of the disease that can be attributed to any of the
studied risk factors. The combined PAR is not a simple summing
up of the individual PARs. A disease case can simultaneously be
attributed to more than one risk factor. As a result, the fraction of
the case population that is attributed to or prevented by each risk
factor overlaps with the fractions attributed to other risk factors.
Hence, the combined PAR is usually lower than the sum of
individual PARs. To estimate the proportion of the disease burden
that is exclusively attributed to a specific risk factor, we calculated
the combined PAR in the presence and absence of this risk factor.
The difference is the ‘‘extra attributable risk,’’ which indicates the
proportion of the disease that can be attributed exclusively to this
specific risk factor [19,21].
Missing values in the complete cohort were imputed with a
linear regression model based on age and sex. No variables had .
2.5% missing values. In the subcohort we did complete case
analyses. Rather than dichotomizing the etiological factors, we
categorized them into as many categories as possible, since this is
presumed to increase the accuracy of the estimated PARs [22].
We estimated PARs for any stroke (ischemic, hemorrhagic, or
unspecified) and for ischemic and hemorrhagic stroke separately.
PARs for any and ischemic stroke were also assessed separately for
men and women [23].
We assessed the PARs of hypertension, smoking, diabetes
mellitus, atrial fibrillation, coronary disease, TC/HDL ratio, and
overweight/obesity in the total cohort of 6,844 participants; we
assessed the PARs of C-reactive protein, alcohol intake, fruit and
vegetable consumption, and carotid IMT in the subcohort of
3,570 participants with complete assessment of those additional
factors. For all strokes and ischemic strokes, we defined the lowest
TC/HDL ratio quartile as the reference category, and for
hemorrhagic strokes we defined the highest TC/HDL ratio
quartile as the reference category, in accordance with current
literature [24]. Interaction between gender and each etiological
risk factor was assessed by entering interaction terms in Cox
proportional hazards models, with age, gender, etiological factor,
and gender6etiological factor as covariates. Statistical significance
was defined at a=0.05.
Results
The complete study cohort comprised 6,844 participants, and
the subgroup with assessment of additional characteristics
comprised 3,570 participants (Table 2). The median age at start
of follow-up was 68 y with interquartile range 62–76 y (mean age
69.4 y, standard deviation 6.3 y), and 60.1% of the participants
were women. The participants in the subgroup with assessment of
additional characteristics differed slightly from those in the
complete study cohort; most notably, they were slightly younger,
more often female, and smoked more.
During 88,011 person-years of follow-up (mean follow-up
12.9 y, standard deviation 6.3 y), 1,020 strokes occurred, of which
610 could be classified as ischemic and 103 as hemorrhagic, and
307 remained unspecified.
When evaluated separately, the most important etiological
factor for any stroke was hypertension, with a PAR of 0.36 (95%
CI 0.26–0.49; Table 3). The second-ranking cause of stroke was
smoking, with a PAR of 0.16 (95% CI 0.10–0.26). Also, diabetes
mellitus (PAR 0.04, 95% CI 0.02–0.07) and atrial fibrillation (PAR
0.02, 95% CI 0.01–0.05) contributed significantly to the burden of
stroke. Coronary disease and overweight/obesity had no statisti-
cally significant impact on the burden of stroke. The total
proportion of strokes that could be attributed to any combination
of these six etiological factors in combination was 0.51 (95% CI
0.41–0.62). TC/HDL ratio was not associated with the risk of
stroke in the expected direction: with the quartile of participants
with the lowest TC/HDL ratios as the reference category, the
hazard ratios were 0.83 (95% CI 0.69–0.99) for the second
quartile, 0.84 (95% CI 0.70–1.00) for the third quartile, and 0.97
(95% CI 0.82–1.16) for the fourth quartile. The participants who
used cholesterol-lowering medication (prevalence 2.3%) had a
slightly lower risk of stroke than those in the lowest quartile of the
TC/HDL ratio distribution, but this difference was not statistically
significant: the HR was 0.71 (95% CI 0.45–1.12). There was no
association between HDL or non-HDL cholesterol with the risk of
stroke when assessed separately (Table 4).
There was no statistically significant interaction between gender
and the studied etiological risk factors at a=0.05. Stratified
analyses for men and women separately can be found in Tables 5–
8.
When we restricted the analyses to ischemic strokes, the PARs
of the individual risk factors did not materially change (Table 9);
the largest observed (non-significant) difference was for over-
weight/obesity, which had a PAR of 0.01 (95% CI 0.00–0.92) for
any stroke and a PAR of 0.12 (95% CI 0.05–0.27) for ischemic
stroke. The total PAR of hypertension, smoking, diabetes mellitus,
atrial fibrillation, coronary disease, overweight/obesity, and
TC/HDL ratio for ischemic stroke was 0.55 (95% CI 0.41–
0.68).
When we studied hemorrhagic strokes (Table 10), smoking was
the most important etiological factor (PAR 0.40, 95% CI 0.22–
0.60), followed by unfavorable TC/HDL ratio (in the case of
hemorrhagic stroke, we considered a low ratio to be unfavorable):
PAR 0.31 (95% CI 0.11–0.63). Hypertension was third, with a
PAR of 0.24 (95% CI 0.04–0.73). Overweight/obesity was not
associated with the risk of hemorrhagic stroke. This resulted in a
total PAR of 0.70 (95% CI 0.45–0.87) for hemorrhagic strokes
attributable to hypertension, smoking, diabetes mellitus, and
unfavorable TC/HDL ratio.
Serum C-reactive protein, fruit and vegetable intake, alcohol
consumption, and carotid IMT were studied in a subcohort of
3,570 participants because of incomplete collection of data in the
other participants. The combined PAR of hypertension, smoking,
diabetes mellitus, atrial fibrillation, coronary disease, and over-
weight/obesity was slightly higher in this subcohort than in the
complete cohort (0.59, 95% CI 0.47–0.71). Addition of serum C-
reactive protein, low fruit and vegetable intake, and high carotid
IMT raised the PAR by 0.06 to 0.65 (95% CI 0.51–0.77;
Table 11). Alcohol consumption was not related with stroke; when
we compared consumption of 0 units and consumption of.3 units
of alcohol per day with the recommended 1 or 2 units per day, the
hazard ratios were 0.99 (95% CI 0.82–1.18) and 0.91 (95% CI
0.70–1.20), respectively.
Discussion
We found that about half of all strokes in our study cohort were
attributable to established modifiable etiological factors, and could
theoretically be prevented by elimination of these risk factors from
the population. Less well established or potentially modifiable
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etiological factors did not materially change this proportion.
Our estimates are considerably lower than those reported
previously.
Several methodological issues need to be discussed. The
strengths of our study are the meticulous stroke case finding and
the nearly complete follow-up (loss of potential person-years,
Table 2. Baseline characteristics.
Characteristic Median (Interquartile Range) or Percentage p-Value for Differencea
Complete Study Cohort
(n=6,844)
Subgroup with Data on Additional Risk
Factors (n=3,570)
Age, y 68.2 (62.0–75.6) 67.7 (62.1–74.0) ,0.001
Female sex 60.1% 60.6% ,0.001
Systolic blood pressure, mm Hg 138 (123–153) 137 (123–152) 0.52
Diastolic blood pressure, mm Hg 73 (66–81) 73 (66–81) 0.68
Antihypertensive medication 12.8% 12.3% 0.56
Current smoking 22.2% 24.1% ,0.001
Former smoking 40.8% 42.3% ,0.001
Diabetes mellitus 10.3% 9.2% 0.15
Atrial fibrillation 5.0% 3.9% 0.04
Angina pectoris 3.6% 2.6% 0.42
PTCA/CABG 2.7% 1.3% 0.64
Symptomatic myocardial infarction 6.1% 6.7% 0.002
TC, mmol/l 6.6 (5.8–7.4) 6.6 (5.9–7.4) 0.01
HDL cholesterol, mmol/l 1.3 (1.1–1.6) 1.3 (1.1–1.6) 0.39
BMI, kg/m2 26.0 (23.8–28.4) 26.0 (23.9–28.4) 0.24
Serum C-reactive protein, mg/l — 1.74 (0.87–3.35) —
Alcohol intake, servings — 0.29 (0.01–1.40) —
Fruit and vegetable intake, servings — 6.6 (5.1–8.2) —
Carotid IMT, mm — 0.77 (0.68–0.86) —
aDifference between participants included and not included in the subgroup with data on additional risk factors. Logistic regression model adjusted for all other
characteristics.
doi:10.1371/journal.pmed.1001634.t002
Table 3. Population attributable risks of presumed etiological factors for any stroke (n/N= 1,020/6,844).
Etiological Factor Stratum
Prevalence
(Percent)
Hazard Ratio
(95% CI)a
PAR (95% CI)a
per Stratum
PAR (95% CI)a
Combined
Hypertension Prehypertension 29.9 1.33 (1.06–1.67) 0.06 (0.02–0.11) 0.36 (0.26–0.49)
Stage I 25.0 1.72 (1.38–2.16) 0.12 (0.07–0.16)
Stage II 14.0 2.00 (1.57–2.55) 0.09 (0.07–0.13)
Treated controlled 5.5 1.89 (1.37–2.59) 0.03 (0.02–0.05)
Treated uncontrolled 7.3 2.18 (1.66–2.86) 0.06 (0.04–0.09)
Smoking Former light 18.2 1.12 (0.93–1.36) 0.02 (0.00–0.09) 0.16 (0.10–0.26)
Former heavy 22.6 1.30 (1.07–1.57) 0.05 (0.03–0.11)
Current light 9.9 1.58 (1.27–1.98) 0.04 (0.02–0.07)
Current heavy 12.4 1.65 (1.32–2.06) 0.05 (0.03–0.07)
Diabetes mellitus Present 10.3 1.43 (1.20–1.71) 0.04 (0.02–0.07)
Atrial fibrillation Present 5.0 1.47 (1.15–1.89) 0.02 (0.01–0.05)
Coronary disease Present 10.0 1.11 (0.91–1.36) 0.01 (0.00–0.08)
BMI Overweight (25–30 kg/m2) 45.4 1.00 (0.87–1.15) 0.00 (0.00–1.00) 0.01 (0.00–0.92)
Obese (.30 kg/m2) 16.6 1.07 (0.89–1.28) 0.01 (0.00–0.17)
Total 0.51 (0.41–0.62)
aAll analyses are adjusted for age, sex, hypertension, smoking, diabetes mellitus, atrial fibrillation, coronary disease, and overweight/obesity, if appropriate. All HRs are
relative to those in whom the etiological factor is not present.
doi:10.1371/journal.pmed.1001634.t003
Modifiable Etiological Factors and the Burden of Stroke
PLOS Medicine | www.plosmedicine.org 5 April 2014 | Volume 11 | Issue 4 | e1001634
2.8%). An advantage of our stringent stroke monitoring proce-
dures was that we could include stroke patients who had not been
referred to a neurologist (31% of all stroke cases). Because in these
cases neuroimaging was not performed, we could subclassify only
21% of them as ischemic or hemorrhagic strokes. In contrast, 93%
of stroke cases that were referred to a neurologist could be
subclassified. Overall, we could not determine the subtype of
stroke in 307 participants.
A statistical issue to note is that the reported lower bound of
some confidence intervals of PARs were close to 0 and therefore
should be interpreted cautiously. The reason is that a PAR cannot
be smaller than 0, which led to some of these confidence intervals
being truncated at 0.
Our study is novel in four important ways. First, previous
studies on the subject were case–control studies, which may have
overestimated the PARs: when risk factors are assessed after
occurrence of stroke in a case–control setting, they are different
than when they are measured before occurrence of stroke in a
cohort study. In addition, previous studies included only strokes
that were referred to a hospital, whereas we also included strokes
that were not referred to a hospital (31% of all cases in our cohort).
Since elderly people tend to be referred less often than younger
people, and the associations between stroke and its risk factors
weaken with increasing age [25], not including the non-referred
strokes may lead to an overestimation of the PARs. Second, not all
previous studies used statistical methods that account for the
possibility that a single stroke can be attributable to multiple
etiological factors [19,20], which may have caused them to
overestimate PARs. Third, some previous studies included risk
factors for which the association with stroke and the causal role in
the etiology are not well established, leading to an overestimation
of the observed associations. Fourth, the PARs that we observed
Table 4. Associations of HDL cholesterol and non-HDL cholesterol with stroke (n= 6,844).
Type of Cholesterol Stratum Hazard Ratio (95% CI)
Any Stroke (n=1,020) Ischemic Stroke (n=610) Hemorrhagic Stroke (n=103)
HDL Quartile 4 1 (reference) 1 (reference) 1 (reference)
Quartile 3 0.80 (0.67–0.95) 0.86 (0.68–1.08) 0.83 (0.44–1.57)
Quartile 2 0.88 (0.74–1.04) 0.83 (0.66–1.04) 1.46 (0.84–2.53)
Quartile 1 0.80 (0.67–0.96) 0.73 (0.57–0.92) 0.20 (0.67–2.17)
Treated (2.2%) 0.67 (0.43–1.05) 0.84 (0.51–1.37) n.a.
Non-HDL Quartile 1 1 (reference) 1 (reference) 1 (reference)
Quartile 2 0.92 (0.78–1.10) 1.03 (0.81–1.30) 0.74 (0.46–1.21)
Quartile 3 0.97 (0.82–1.16) 1.23 (0.97–1.54) 0.54 (0.32–0.92)
Quartile 4 0.87 (0.73–1.04) 1.10 (0.86–1.38) 0.37 (0.20–0.67)
All analyses adjusted for age and sex, and computed with IBM SPSS Statistics, version 21.
n.a., not applicable because stratum without events.
doi:10.1371/journal.pmed.1001634.t004
Table 5. Population attributable risks of presumed etiological factors for any stroke: men (n/N= 406/2,732).
Probable Etiological
Factor Stratum
Prevalence
(Percent)
Hazard Ratio
(95% CI)a
PAR (95% CI)a
per Stratum
PAR (95% CI)a
Combined
Hypertension Prehypertension 31.4 1.47 (1.04–2.09) 0.09 (0.04–0.21) 0.39 (0.23–0.57)
Stage I 24.4 1.89 (1.33–2.68) 0.13 (0.08–0.22)
Stage II 12.3 2.41 (1.64–3.52) 0.11 (0.07–0.16)
Treated controlled 6.1 1.55 (0.92–2.63) 0.02 (0.01–0.07)
Treated uncontrolled 7.3 1.85 (1.17–2.93) 0.04 (0.02–0.08)
Smoking Former light 19.7 1.24 (0.81–1.91) 0.04 (0.01–0.22) 0.25 (0.07–0.58)
Former heavy 41.6 1.30 (0.87–1.94) 0.10 (0.02–0.35)
Current light 9.8 1.43 (0.88–2.32) 0.03 (0.01–0.11)
Current heavy 19.4 1.65 (1.08–2.53) 0.08 (0.03–0.17)
Diabetes mellitus Present 10.1 1.46 (1.08–1.96) 0.04 (0.02–0.10)
Atrial fibrillation Present 5.6 1.27 (0.85–1.91) 0.01 (0.00–0.08)
Coronary disease Present 14.9 1.19 (0.91–1.57) 0.03 (0.01–0.13)
BMI Overweight (25–30 kg/m2) 50.0 1.14 (0.92–1.41) 0.07 (0.01–0.29) 0.07 (0.01–0.32)
Obese (.30 kg/m2) 8.3 1.10 (0.76–1.59) 0.01 (0.00–0.33)
Total 0.61 (0.42–0.77)
aAll analyses are adjusted for age, sex, hypertension, smoking, atrial fibrillation, and diabetes mellitus, if appropriate.
doi:10.1371/journal.pmed.1001634.t005
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are considerably lower than most PARs reported previously, which
is an important counterbalance for previous findings.
A comparison of the PARs of individual etiological factors in our
study with those reported previously shows that the PARs of most
factors tended to be slightly lower in our study than in earlier
reports, with the exception of smoking, which had a similar PAR
[3]. Several explanations are possible. First, selection bias may
have played a role in earlier estimates, since strong associations
tend to be more easily published than weak associations. Second,
our study participants are aware of their cardiovascular risk status
because of their participation in the study. The healthcare system
in the study district is well developed and accessible to everyone
without substantial financial barriers. Therefore, most participants
have their risk factors treated according to up-to-date guidelines.
Third, our study participants all live in a middle and high income
area in the city, and .97% are Caucasians. As a result, poverty-
related health problems are rare. The prevalence of, for example,
alcoholism, malnourishment, diabetes, and overweight/obesity is
relatively low in our study population compared to other
populations. This means that our results may not be generalizable
to underprivileged or racially diverse populations. Fourth, we did
not dichotomize the etiological factors but categorized them,
which may have resulted in more accurate estimates [22]. Fifth, all
risk factors were assessed at baseline. During follow-up, which was
on average 12.9 y, risk factor profiles of individual participants
may have changed, which could have weakened the associations
we found. Sixth, the median age at start of follow-up of our study
participants was relatively high (median 68 y), and the relation
between stroke and its etiological factors weakens with increasing
age [25].
Only a few previous studies have reported PARs of combinations
of classical etiological factors for stroke. An overview of these
Table 6. Population attributable risks of presumed etiological factors for any stroke: women (n/N= 614/4,112).
Probable Etiological
Factor Stratum
Prevalence
(Percent)
Hazard Ratio
(95% CI)a
PAR (95% CI)a
per Stratum
PAR (95% CI)a
Combined
Hypertension Prehypertension 28.9 1.23 (0.91–1.66) 0.04 (0.01–0.16) 0.34 (0.20–0.51)
Stage I 25.3 1.61 (1.20–2.16) 0.11 (0.06–0.18)
Stage II 15.2 1.77 (1.29–2.42) 0.08 (0.05–0.14)
Treated controlled 5.0 2.05 (1.37–3.06) 0.04 (0.02–0.07)
Treated uncontrolled 7.3 2.27 (1.61–3.20) 0.07 (0.04–0.11)
Smoking Former light 17.2 1.07 (0.85–1.35) 0.01 (0.00–0.25) 0.12 (0.07–0.20)
Former heavy 10.0 1.37 (1.05–1.79) 0.03 (0.01–0.07)
Current light 9.9 1.74 (1.34–2.26) 0.05 (0.03–0.09)
Current heavy 7.7 1.76 (1.28–2.42) 0.03 (0.02–0.06)
Diabetes mellitus Present 10.4 1.40 (1.11–1.75) 0.04 (0.02–0.09)
Atrial fibrillation Present 4.5 1.71 (1.24–2.35) 0.03 (0.01–0.06)
Coronary disease Present 6.8 1.05 (0.78–1.41) 0.00 (0.00–0.65)
BMI Overweight (25–30 kg/m2) 42.4 0.92 (0.76–1.10) n.a. n.a.
Obese (BMI.30 kg/m2) 22.1 1.02 (0.82–1.26) 0.01 (0.00–1.00)
Total 0.46 (0.33–0.60)
aAll analyses are adjusted for age, sex, hypertension, smoking, atrial fibrillation, and diabetes mellitus, if appropriate.
n.a., not applicable because the hazard ratio is smaller than one.
doi:10.1371/journal.pmed.1001634.t006
Table 7. Population attributable risks of presumed etiological factors for ischemic stroke: men and women.
Probable Etiological Factor PAR (95% CI)
a
Men (n/N=263/2,732) Women (n/N=347/4,112)
Hypertension 0.38 (0.20–0.60) 0.28 (0.12–0.53)
Smoking 0.24 (0.05–0.67) 0.12 (0.05–0.25)
Diabetes mellitus 0.03 (0.01–0.12) 0.03 (0.01–0.11)
Atrial fibrillation n.a. 0.02 (0.01–0.07)
Coronary disease 0.07 (0.03–0.15) 0.00 (0.00–1.00)
Overweight/obesity 0.15 (0.05–0.37) 0.10 (0.02–0.38)
TC/HDL ratio n.a. 0.13 (0.03–0.45)
Total 0.64 (0.41–0.82) 0.56 (0.30–0.80)
aAll analyses are adjusted for age, sex, hypertension, smoking, atrial fibrillation, and diabetes mellitus, if appropriate.
n.a., not applicable because the hazard ratio is smaller than one.
doi:10.1371/journal.pmed.1001634.t007
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studies can be found in Table 12. All of these studies were case–
control studies or were based on previous literature. The
Comparative Risk Assessment project, which based the prevalence
of etiological factors and their associations with stroke on previous
literature, found a total PAR of 0.70–0.76 [26]. A case–control
study conducted in Rochester, Minnesota, US, reported a total
PAR of 0.57 (95% CI 0.48–0.67), which after inclusion of
emerging risk factors increased to 0.80 [2]. The INTERSTROKE
study, a case–control study in 22 countries, found a total PAR of
0.90 (95% CI 0.85–0.94) [7]. A case–control study from the Sa˜o
Vicente de Paulo Hospital in Oso´rio, Brazil, reported a total PAR
of 0.99 (95% CI 0.96–1.00) [6]. We estimated the total PAR of
established modifiable etiological factors to be 0.51 (95% CI 0.41–
0.62) for stroke, which is considerably lower than that reported in
these previous studies.
There are several explanations why our estimates of the total
PAR are lower than reported previously, in addition to the slightly
lower estimates of PARs for individual risk factors. First, our study
is a cohort study, whereas all previous studies that reported a total
PAR were case–control studies [2,6,7,26]. The latter studies could
overestimate the PAR because of reverse causality (risk factors
were assessed after and not before occurrence of stroke) and
because strokes that were not referred to a hospital (31% of cases
in our study) were not included. Second, to combine the PARs of
multiple etiological factors, special statistical techniques have to be
applied: with inadequate techniques (when only confounding and
interaction are corrected for, and a disease case cannot
simultaneously be attributed to more than one risk factor), total
PARs are very likely to be overestimated and can even exceed
100% [18]. Third, the various studies selected slightly different
etiological factors, as specified in Table 12. This could also have
played a role in the observed differences. As mentioned, we
selected the etiological factors in our study based on the 2011
American Heart Association/American Stroke Association guide-
lines [3] and the data that were available. We had no information
on physical inactivity: it has been shown that physically active
persons have a 25%–30% lower risk of stroke than the least active
persons, although no intervention trials have been performed [3].
The association between physical activity and stroke is at least
partly mediated by blood pressure, diabetes, and body weight [3],
for which we did have data. We may have slightly underestimated
the total PAR because of lack of data on physical activity. Lack of
data on other factors (Table 1) probably did not materially
influence our total PAR, because the causality for these factors has
not been established, and either the previously found associations
were weak or the factors are rare in the general population [3].
It should be kept in mind that the causal role and the
modifiability of the majority of these factors have not been
established and are in some instances even unlikely. For example,
C-reactive protein levels are consistently associated with the risk of
cardiovascular disease, but genetic studies negate the causality of
Table 8. Population attributable risks of presumed etiological factors for which data were available only for subgroups, for any
stroke: men and women.
Etiological Factor PAR (95% CI)
a Combined
Men (n/N=215/1,405) Women (n/N=330/2,165)
Previous total PARb 0.74 (0.50–0.89) 0.49 (0.32–0.66)
Serum C-reactive protein 0.06 (0.00–0.85) 0.06 (0.00–0.67)
Fruit and vegetable intakec 0.09 (0.03–0.23) 0.00 (0.00–1.00)
Carotid IMT 0.09 (0.01–0.69) 0.16 (0.04–0.49)
Grand total 0.76 (0.54–0.90) 0.56 (0.34–0.75)
aAll analyses are adjusted for age, sex, hypertension, smoking, diabetes mellitus, atrial fibrillation, coronary disease, and overweight/obesity, if appropriate.
bTotal PAR based on hypertension, smoking, diabetes mellitus, atrial fibrillation, coronary disease, and overweight/obesity, calculated in this subgroup of the study
population.
cVery low intake (,3 servings per day) and low intake (3–5 servings per day) versus adequate intake (.5 servings per day) of fruits and/or vegetables.
doi:10.1371/journal.pmed.1001634.t008
Table 9. Population attributable risks of presumed etiological
factors for ischemic stroke.
Etiological Factor PAR (95% CI)a (n/N=610/6,844)
Hypertension 0.33 (0.20–0.49)
Smoking 0.16 (0.08–0.30)
Diabetes mellitus 0.03 (0.01–0.08)
Atrial fibrillation 0.00 (0.00–0.16)
Coronary disease 0.03 (0.01–0.08)
Overweight/obesity 0.12 (0.05–0.27)
TC/HDL ratio 0.03 (0.00–0.82)
Total 0.55 (0.41–0.68)
aAll analyses are adjusted for age, sex, hypertension, smoking, diabetes mellitus,
atrial fibrillation, coronary disease, TC/HDL ratio, and overweight/obesity, if
appropriate. Category boundaries for quartiles of TC/HDL ratio were 4.38, 5.30,
and 6.42 for men and 3.94, 4.78, and 5.82 for women.
doi:10.1371/journal.pmed.1001634.t009
Table 10. Population attributable risks of presumed
etiological factors for hemorrhagic stroke.
Etiological Factor PAR (95% CI)a (n/N=103/6,844)
Hypertension 0.24 (0.04–0.73)
Smoking 0.40 (0.22–0.60)
Diabetes mellitus 0.03 (0.00–0.26)
TC/HDL ratiob 0.31 (0.11–0.63)
Total 0.70 (0.45–0.87)
aAll analyses are adjusted for age, sex, hypertension, smoking, diabetes mellitus,
and TC/HDL ratio, if appropriate.
bThe quartile with the highest ratio was the reference category. Category
boundaries for quartiles of TC/HDL ratio were 6.42, 5.30, and 4.38 for men and
5.82, 4.78, and 3.94 for women.
doi:10.1371/journal.pmed.1001634.t010
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Table 11. Population attributable risks of presumed etiological factors for which data were available only for subgroups, for any
stroke (n/N= 545/3,570).
Etiological Factor Classification
Prevalence
(Percent)
Hazard Ratio
(95% CI)a
PAR (95% CI)a
per Classification
PAR (95% CI)a
Combined
Previous total PARb 0.59 (0.47–0.71)
Serum C-reactive
protein
Quartile 2 25 1.06 (0.82–1.36) 0.01 (0.00–0.58) 0.06 (0.00–0.54)
Quartile 3 25 1.04 (0.81–1.34) 0.01 (0.00–0.87)
Quartile 4 25 1.13 (0.88–1.46) 0.03 (0.00–0.21)
Fruit and vegetable
intake
3–5 servings 20 1.21 (0.99–1.47) 0.04 (0.01–0.12) 0.04 (0.01–0.13)
,3 servings 4 0.96 (0.60–1.55) n.a.
Carotid IMT Quartile 2 25 1.00 (0.76–1.32) 0.00 (0.00–1.00) 0.14 (0.04–0.40)
Quartile 3 25 1.20 (0.91–1.57) 0.05 (0.01–0.18)
Quartile 4 25 1.38 (1.05–1.81) 0.09 (0.04–0.20)
Grand total 0.65 (0.51–0.77)
Category boundaries for C-reactive protein quartiles were 0.896, 1.900, and 3.960 for men and 0.902, 1.830, and 3.360 for women. Category boundaries for carotid IMT
quartiles were 0.72, 0.80, and 0.92 for men and 0.67, 0.76, and 0.85 for women.
aAll analyses are adjusted for age, sex, hypertension, smoking, diabetes mellitus, atrial fibrillation, coronary disease, and overweight/obesity, if appropriate.
bTotal PAR based on hypertension, smoking, diabetes mellitus, atrial fibrillation, coronary disease, and overweight/obesity, calculated in this subgroup of the study
population.
n.a., not applicable because the hazard ratio is smaller than one.
doi:10.1371/journal.pmed.1001634.t011
Table 12. Studies reporting total population attributable risk for stroke.
Study Publication Year Design Outcome Included Variables PAR (95% CI)
Comparative Risk
Assessment project [26]
2003 Multiple Stroke High blood pressure, high
cholesterol, high BMI, low fruit
and vegetable intake, physical
inactivity, tobacco, alcohol
0.70–0.76
Rochester [2] 2006 Case–control Ischemic stroke Established causal factors
(hypertension, transient ischemic
attack, cigarette smoking, ischemic
heart disease, atrial fibrillation,
diabetes mellitus, mitral valve
disease); emerging novel risk
factors (raised apoB/apoA 1
ratio, obesity, physical inactivity,
pyschosocial stress, low fruit and
vegetable intake)
0.57 (0.48–0.67); 0.80 if
emerging risk factors are
included
INTERSTROKE [7] 2010 Case–control Stroke Self-reported hypertension,
smoking status, waist-to-hip ratio,
diet risk score, regular physical
activity, diabetes mellitus, alcohol
intake, psychosocial factors, cardiac
causes, ratio of ApoB to ApoA1
0.90 (0.85–0.94)
Sa˜o Vicente de Paulo
Hospital [6]
2012 Case–control Ischemic stroke Hypertension, atrial fibrillation,
left ventricular hypertrophy,
presence of carotid bruit, heavy
smoking status, diabetes, alcohol
abuse, HDL cholesterol, physical
inactivity
0.99 (0.96–1.00)
Rotterdam Study (present
study)
2014 Cohort Stroke, ischemic stroke,
hemorrhagic stroke
Hypertension, smoking,
diabetes mellitus, atrial
fibrillation, coronary heart
disease, overweight/obesity,
TC/HDL ratio
0.51 (0.41–0.62) for stroke;
0.55 (0.41–0.68) for
ischemic stroke; 0.70
(0.45–0.87) for
hemorrhagic stroke
doi:10.1371/journal.pmed.1001634.t012
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the association. C-reactive protein is not really modifiable in and
of itself, and presumably is merely a marker of other presently
unknown risk factors. Therefore, it is difficult to modify C-reactive
protein or its underlying cause [27].
The relationship between cholesterol and stroke is controversial.
The most widely accepted hypothesis is that with increasing serum
levels of TC and decreasing serum levels of HDL cholesterol, the
risk of ischemic stroke slightly increases and the risk of
hemorrhagic stroke decreases [3,24]. Our results corroborate this
view. It is possible that in our study the contrasting relationships
that cholesterol has with ischemic and hemorrhagic stroke
annulled the association between cholesterol and any stroke.
The theoretical positive effect of cholesterol treatment per se on
ischemic stroke risk may be frustrated by a negative effect on
hemorrhagic stroke risk. However, trials have shown that
treatment with statins prevents strokes, although it cannot be
excluded that pleiotropic effects beyond cholesterol modification
account for the beneficial effect of statins [28].
It should be noted that the proportion of strokes that can
actually be prevented is in practice probably lower than suggested
by the PAR, for several reasons. First, if a stroke is prevented
successfully in a person, this person can still suffer later in life from
stroke due to other causes. Second, it is unlikely that risk factors
can be eliminated completely. For example, we assumed that
blood pressure should be maintained below 120/80 mm Hg, but
evidently it is not possible to attain such a blood pressure level in
all persons. Third, we assumed that all risk factors we studied are
modifiable, and that modification reverses the complete excess risk
that is portended by the risk factor. This, too, is unlikely: not only
because the modifiable factors may, at least partially, be markers
of other factors that may not be modifiable, but also because risk
factors may already have caused irreversible damage at the time
that treatment is initiated.
It is uncertain whether all variation in stroke occurrence can be
explained by modifiable etiological factors; we consider it likely
that a large proportion of the variation in stroke occurrence can
only be explained by non-modifiable factors, and even the role of
chance should not be underestimated.
In conclusion, our data suggest that half of all strokes in persons
aged 55 y and over might theoretically be prevented by optimal
treatment or elimination of hypertension, smoking, diabetes
mellitus, atrial fibrillation, coronary disease, and overweight/
obesity. Our findings underscore the importance of hypertension
and smoking as etiological factors for stroke, and encourage
continuing interventions on these factors. On the other hand, our
data suggest that a considerably larger proportion of strokes than
commonly assumed cannot be prevented by interventions on
currently known etiological factors, and show the importance of
the search for novel etiological factors.
In our opinion, our results underscore that the battle against
smoking should continue until smoking is banned entirely. In
addition, the cost-effectiveness of population screening for
hypertension and blood pressure treatment in medium-risk
populations should be further explored, because even in our study
population with 100% blood pressure awareness, hypertension is
still the main cause of stroke. Easier treatment regimens might
make it easier for persons with hypertension to adhere to their
medication. Last, the quest for new etiological factors may identify
new treatment targets. Emerging radiological techniques enable
the imaging of intracranial atherosclerosis, which may lead to new
ways to prevent stroke [29]. The fields of epigenomics and
proteomics hold undelivered promises to identify yet unknown
modifiable risk factors [2].
Supporting Information
Checklist S1 STROBE checklist.
(PDF)
Acknowledgments
The contributions of the inhabitants, general practitioners, and pharma-
cists of the Ommoord district to the Rotterdam Study are gratefully
acknowledged.
Author Contributions
Conceived and designed the experiments: MJB PJK AH MAI. Analyzed
the data: MJB. Wrote the first draft of the manuscript: MJB. Contributed
to the writing of the manuscript: MJB PJK AH MAI. ICMJE criteria for
authorship read and met: MJB PJK AH MAI. Agree with manuscript
results and conclusions: MJB PJK AH MAI. Case ascertainment: MJB
PJK.
References
1. (1967) Effects of treatment on morbidity in hypertension. Results in patients with
diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202: 1028–
1034.
2. Hankey GJ (2006) Potential new risk factors for ischemic stroke: what is their
potential? Stroke 37: 2181–2188.
3. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, et al. (2011)
Guidelines for the primary prevention of stroke: a guideline for healthcare
professionals from the American Heart Association/American Stroke Associa-
tion. Stroke 42: 517–584.
4. Rothman KJ, Greenland S, editors (1998) Modern epidemiology, 2nd edition.
Philadelphia: Lippincott Williams & Wilkins.
5. Rothman KJ GS (1998) Causation and causal inference. In: Rothman KJ,
Greenland S, editors. Modern epidemiology, 2nd edition. Philadelphia:
Lipincott Williams & Wilkins. pp. 7–28.
6. Mallmann AB, Fuchs SC, Gus M, Fuchs FD, Moreira LB (2012) Population-
attributable risks for ischemic stroke in a community in South Brazil: a case-
control study. PLoS ONE 7: e35680.
7. O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, et al. (2010) Risk factors for
ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTER-
STROKE study): a case-control study. Lancet 376: 112–123.
8. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, et
al. (2013) The Rotterdam Study: 2014 objectives and design update.
Eur J Epidemiol 28: 889–926.
9. Hatano S (1976) Experience from a multicentre stroke register: a preliminary
report. Bull World Health Organ 54: 541–553.
10. Bos MJ, van Rijn MJ, Witteman JC, Hofman A, Koudstaal PJ, et al. (2007)
Incidence and prognosis of transient neurological attacks. JAMA 298: 2877–
2885.
11. Clark TG, Altman DG, De Stavola BL (2002) Quantification of the
completeness of follow-up. Lancet 359: 1309–1310.
12. Rose GA (1962) The diagnosis of ischaemic heart pain and intermittent
claudication in field surveys. Bull World Health Organ 27: 645–658.
13. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, et al. (2006)
High serum C-reactive protein level is not an independent predictor for stroke:
the Rotterdam Study. Circulation 114: 1591–1598.
14. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common
carotid intima-media thickness and risk of stroke and myocardial infarction: the
Rotterdam Study. Circulation 96: 1432–1437.
15. van den Brandt PA, Goldbohm RA, van ’t Veer P, Volovics A, Hermus RJ, et al.
(1990) A large-scale prospective cohort study on diet and cancer in The
Netherlands. J Clin Epidemiol 43: 285–295.
16. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM (2006) Uric acid
is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke
37: 1503–1507.
17. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, et al.
(2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287:
3223–3229.
18. Gail D (2002) Interactive Risk Attributable Program, version 2.2 [computer
program]. Available: http://dceg.cancer.gov/tools/risk-assessment/irap. Ac-
cessed 28 March 2014.
Modifiable Etiological Factors and the Burden of Stroke
PLOS Medicine | www.plosmedicine.org 10 April 2014 | Volume 11 | Issue 4 | e1001634
19. Dehghan A, van Hoek M, Sijbrands EJ, Stijnen T, Hofman A, et al. (2007) Risk
of type 2 diabetes attributable to C-reactive protein and other risk factors.
Diabetes Care 30: 2695–2699.
20. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, et al. (2003)
Population attributable risks of esophageal and gastric cancers. J Natl Cancer
Inst 95: 1404–1413.
21. Walter SD (1998) Attributable risk in practice. Am J Epidemiol 148: 411–413.
22. Greenland S (2001) Attributable fractions: bias from broad definition of
exposure. Epidemiology 12: 518–520.
23. Bushnell CD (2008) Stroke and the female brain. Nat Clin Pract Neurol 4: 22–33.
24. Wang X, Dong Y, Qi X, Huang C, Hou L (2013) Cholesterol levels and risk of
hemorrhagic stroke: a systematic review and meta-analysis. Stroke 44: 1833–1839.
25. Whisnant JP (1997) Modeling of risk factors for ischemic stroke. The Willis
Lecture. Stroke 28: 1840–1844.
26. Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, et al. (2003)
Estimates of global and regional potential health gains from reducing multiple
major risk factors. Lancet 362: 271–280.
27. C Reactive Protein Coronary Heart Disease Genetics Collaboration, Wensley F,
Gao P, Burgess S, Kaptoge S, et al. (2011) Association between C reactive
protein and coronary heart disease: Mendelian randomisation analysis based on
individual participant data. BMJ 342: d548.
28. Castilla Guerra L, del Carmen Fernandez Moreno M, Lopez Chozas JM,
Jimenez Hernandez MD (2008) Statins in stroke prevention: what an internist
should know. Eur J Intern Med 19: 8–14.
29. Bos D, Portegies ML, van der Lugt A, Bos MJ, Koudstaal PJ, et al. (2014)
Intracranial carotid artery atherosclerosis and the risk of stroke in whites: the
Rotterdam study. JAMA Neurol. E-pub ahead of print. doi:10.1001/
jamaneurol.2013.6223
Modifiable Etiological Factors and the Burden of Stroke
PLOS Medicine | www.plosmedicine.org 11 April 2014 | Volume 11 | Issue 4 | e1001634
Editors’ Summary
Background. Every year, 15 million people worldwide have
a stroke. About 6 million of these people die within hours,
and another 5 million are left disabled. Stroke occurs when
the brain’s blood supply is suddenly interrupted by a blood
vessel in the brain being blocked by a blood clot (ischemic
stroke) or bursting (hemorrhagic stroke). Deprived of the
oxygen normally carried to them by the blood, the brain cells
near the blockage die. The symptoms of stroke depend on
which part of the brain is damaged but include sudden
weakness or paralysis along one side of the body, vision loss
in one or both eyes, and trouble speaking or understanding
speech. Anyone experiencing these symptoms should seek
immediate medical attention because prompt treatment can
limit the damage to the brain. In the longer term, post-stroke
rehabilitation can help overcome the disabilities caused by
stroke, and various drugs alongside behavioral counselling
can reduce the risk of a second stroke.
Why Was This Study Done? Fifty years ago, it was
discovered that treatment of high blood pressure (hyper-
tension) reduces the risk of stroke among people with severe
hypertension. This discovery led researchers to search for
other potentially modifiable etiological factors for stroke (risk
factors that cause stroke). The list of established etiological
factors now includes smoking, diabetes, atrial fibrillation (an
irregular heartbeat), heart disease, and overweight/obesity,
in addition to hypertension. But how many strokes would
modification of these causal risk factors prevent? In this
population-based cohort study, the researchers calculate the
individual and combined population attributable risks (PARs)
for these established etiological factors to provide an
estimate of what proportion of strokes could theoretically
be prevented by optimal treatment of known etiological
factors. A population-based cohort study enrolls a group of
people, determines their characteristics at baseline, and
follows them to see whether specific characteristics are
associated with specific outcomes. A PAR of an etiological
factor for a disease indicates the proportion of that disease in
the population that would not occur in the absence of the
risk factor.
What Did the Researchers Do and Find? The researchers
used data from 6,844 participants in the Rotterdam Study,
which was designed to investigate the causes and conse-
quences of long-term and disabling diseases in the elderly.
At baseline, all of the participants were over 55 years old and
free from stroke. During follow-up, 1,020 strokes occurred
among the participants. Using data on exposure at baseline
to various etiological factors for stroke, the researchers
calculated PARs for individual factors and used a special
statistical technique to calculate PARs for the factors in
combination. The combined PAR of prehypertension/hyper-
tension, smoking, diabetes, atrial fibrillation, heart disease,
and overweight/obesity was 0.51 for any stroke. That is,
about half of the strokes in the study population were
attributable to this combination of etiological factors.
Hypertension and smoking were the most important
individual factors (PARs of 0.36 and 0.16, respectively).
Notably, the inclusion of several less well established
etiological factors (increased blood levels of C-reactive
protein, low fruit and vegetable consumption, and thicken-
ing of the lining of arteries) only raised the total PAR for any
stroke by 0.06.
What Do These Findings Mean? These findings indicate
that about half of the strokes in the study cohort were
attributable to established modifiable etiological factors and
could theoretically be prevented by eliminating these risk
factors from the population. Previous studies have estimated
that a larger proportion of strokes could be prevented by
eliminating known etiological factors. The researchers
acknowledge that some aspects of their study may have
led to an underestimation of the proportion of stroke
attributable to established etiological factors and note that
their findings may not be generalizable to underprivileged or
racially diverse populations. Nevertheless, they argue that
previous studies are likely to have overestimated the PARs
for stroke because they were based on case–control studies
(in which exposure to etiological factors was assessed after a
stroke had occurred in cases and control individuals, rather
than before a stroke as in a population-based cohort study)
and often did not use optimal statistical techniques to
calculate the total PAR. Importantly, these new findings
underscore the importance of interventions targeted at
reducing smoking and hypertension and support the search
for additional etiological factors for stroke.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001634.
N The US National Institute of Neurological Disorders and
Stroke provides information about all aspects of stroke (in
English and Spanish); its Know Stroke site provides
educational materials about stroke prevention, treatment,
and rehabilitation including personal stories (in English
and Spanish); the US National Institutes of Health
SeniorHealth website has additional information about
stroke
N The Internet Stroke Center provides detailed information
about stroke for patients, families, and health professionals
(in English and Spanish)
N The UK National Health Service Choices website also
provides information about stroke for patients and their
families, including personal stories
N MedlinePlus has links to additional resources about stroke
(in English and Spanish)
N Information about the Rotterdam Study is available
N The UK not-for-profit website Healthtalkonline provides
personal stories about stroke
Modifiable Etiological Factors and the Burden of Stroke
PLOS Medicine | www.plosmedicine.org 12 April 2014 | Volume 11 | Issue 4 | e1001634
